U.S. RESEARCH ROUNDUP-Arm Holdings, Expensify, New Relic

Sight Sciences

15/09/2023 08:33

Sept 15 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S. listed companies, including Arm Holdings, Expensify and New Relic on
Friday. 

  HIGHLIGHTS 
                 * Arm Holdings Plc  ARM.O : Needham inititaes with hold rating 
 
                 * Expensify Inc  EXFY.O : JP Morgan initiates coverage with underweight rating 
 
                 * New Relic Inc  NEWR.N : D.A. Davidson cuts to neutral from buy 
 
 
Following is a summary of research actions on U.S. companies reported by Reuters on Friday.
Stock entries are in alphabetical order.  

                 * Adobe Inc  ADBE.O : Baird raises target price to $540 from $500 
 
                 * Alcoa Corp  AA.N : JP Morgan cuts target price to $28 from $35 
 
                 * Arm Holdings Plc  ARM.O : Needham inititaes with hold rating 
 
                 * Arthur J. Gallagher & Co.  AJG.N : Jefferies raises target price to $262 from $249 
 
                 * Arthur J. Gallagher & Co.  AJG.N : KBW raises target price to $222 from $221 
 
                 * Broadcom Inc  AVGO.O : Daiwa Capital Markets raises target price to $925 from $900 
 
                 * Copart Inc  CPRT.O : Jefferies raises target price to $52 from $47.5 
 
                 * Delta Air Lines Inc  DAL.N : TD Cowen cuts target price to $55 from $60 
 
                 * Doubleverify Holdings Inc  DV.N : Piper Sandler cuts target price to $40 from $45 
 
                 * Expensify Inc  EXFY.O : JP Morgan initiates coverage with underweight rating 
 
                 * Frontier Communications Parent Inc  FYBR.O : JP Morgan cuts target price to $33 from
 $35 
 
                 * Hain Celestial Group Inc  HAIN.O : Jefferies cuts target price to $11 from $13 
 
                 * New Relic Inc  NEWR.N : D.A. Davidson cuts target price to $87 from $95 
 
                 * New Relic Inc  NEWR.N : D.A. Davidson cuts to neutral from buy 
 
                 * Olema Pharmaceuticals Inc  OLMA.O : JP Morgan raises target price to $19 from $16 
 
                 * Sight Sciences Inc  SGHT.O : Citigroup cuts price target to $4 from $8 
 
                 * STAAR Surgical Co  STAA.O : Canaccord Genuity cuts target price to $43 from $48 
 
                 * STAAR Surgical Co  STAA.O : Jefferies cuts target price to $60 from $62 
 
                 * STAAR Surgical Co  STAA.O : Piper Sandler cuts target price to $45 from $50 
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))